Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slumped 0.40% to $67.24 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.65% to 3,936.97 and Dow Jones Industrial Average falling 1.63% to 32,030.11. The stock's fall snapped a two-day winning streak. Bristol Myers Squibb Co. closed $14.20 short of its 52-week high ($81.44), which the company reached on December 1st.
Despite its losses, the stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 1.85% to $151.05, Pfizer Inc. (PFE) fell 1.60% to $40.01, and Abbott Laboratories (ABT) fell 1.49% to $96.86.true Trading volume (6.7 M) remained 1.8 million below its 50-day average volume of 8.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 22, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 22, 2023 16:42 ET (20:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.